FDA Approved: DARZALEX — Original Application (Janssen Biotech, Inc.)

View source ↗

Summary

FDA approved the original application for DARZALEX (daratumumab) from Janssen Biotech, Inc., establishing its use for treating multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DARZALEX (daratumumab)

Snippet

ORIG AP for DARZALEX (DARATUMUMAB)